Buy & Sell ResMed Inc. (RMD) – ResMed Inc. Price Today
Aura AI Summary
Key Stats
- $29.61BMarket Cap
- HealthSector
- -23.79%3M Drawdown
- $28.80BEnterprise Value
- 1.18%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 62 daysTypical Hold Time
ResMed Inc. (RMD) is currently valued at a market capitalization of $29.61B, with an enterprise value of $28.80B. Over the past 52 weeks, ResMed Inc. has traded between a low of $198.76 and a high of $293.73, highlighting its annual price range. Over the past three months, ResMed Inc. has recorded a drawdown of -23.79%, reflecting recent price volatility. ResMed Inc. offers a dividend yield of 1.18%, with the most recent dividend of $0.60 paid on 14 May 26. On average, investors hold ResMed Inc. for approximately 62 days, indicating typical investor behavior on the platform.
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Most Recent News
Bill Ackman's sale of Alphabet shares cost $641M; Microsoft bet offsets some losses but not all.
In Q1 2026, Bill Ackman sold 95% of his Alphabet shares, missing out on $641 million in gains as the stock surged. He shifted his investment to Microsoft, which gained $271.8 million since the end of the quarter, partially offsetting the losses. Ackm...
Short seller warns Everspin stock is overvalued amid AI hype, predicts 60% downside.
Kerrisdale Capital has taken a short position on Everspin Technologies, arguing the recent surge in its stock price is driven by misplaced enthusiasm around AI-related memory demand. Everspin's MRAM technology targets niche industrial markets rather ...
Vuzix showcases advanced waveguide smart glasses for defense at SOF Week 2026 in Florida
Vuzix Corporation is exhibiting its advanced AI-powered smart glasses and waveguide solutions at SOF Week 2026 in Tampa, Florida. These products are designed for defense use, offering mission-ready optical performance in challenging environments, inc...